Theranostic Iron-Oxide Based Nanoplatforms in Oncology

Mohammad-Nabil Savari completed his masters of medical nanotechnology at Tehran Medical Branch, IAU, Tehran, Iran. He had a master's semester in pathogenic microbiology at UT and received his bachelor's degree in biology from SBU. His research is currently focused on designing multifunctional nanoplatforms for multimodal treatment of glioblastoma multiforme. And he asks for cooperation from all researchers in this field.Dr. Ali Jabali, a specialist in medical nanotechnology, obtained his doctorate at Shahid Beheshti University, Iran, and completed a post-doctoral course at the University of Zaragoza, Spain. Currently, he is a member of the academic staff of Tehran Azad University of Medical Sciences, Iran, and he is teaching and researching in the field of nanotechnology. Designing new and engineered nanoparticles is one of his goals, and applying smart nanoparticles is one of his dreams. He is currently working on various national and international projects, and all researchers are invited to cooperate.

• Introduction.- Drug conjugation chemistry in iron oxide nanoparticles (IONPs).- Superparamagnetic iron oxide nanoparticle (SPION) Synthesis.- Properties of Iron oxide nanoparticles (IONPs).- Pharmacokinetics of IONPs.- Magnetic Nanoparticles in Stimuli-Responsive Drug Delivery Systems.- IONPs-based treatment methods.- Diagnosis.- Biosensing.- Bioassays Based on Magnetic Phenomena.- Cytotoxicity/toxicity.- Coatings.- Concluding remarks and future perspectives.